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ABSTRACT 
Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory 
symptoms and airflow limitation. Apart from the ventilatory limitations, patients with COPD 
present an impaired exercise capacity that limits their ability to perform the activities of daily living 
and impacts negatively on their quality of life. Limb muscle dysfunction is a systemic consequence 
of COPD associated with exercise intolerance, poor quality of life and increased mortality. This 
COPD-related syndrome is characterized by reduced muscle cross-sectional area, strength and 
endurance, and is highly prevalent among COPD patients. Thus, pulmonary rehabilitation (PR) is 
recommended in order to combat the negative consequences of COPD on patients’ exercise capacity 
and quality of life. Exercise training is regarded as the cornerstone of PR and can be implemented at 
any stage of the disease. To date, the combination of resistance and endurance training (i.e. 
concurrent training) has demonstrated to be the most beneficial exercise intervention in COPD. 
Concurrent training provides clinically and statistically significant benefits in exercise tolerance 
and quality of life to patients with COPD. In addition, there are other potential adjuncts to exercise 
training and strategies to enhance the implementation of PR programs in COPD patients. 
Keywords: resistance training, strength training, endurance training, lung disease, exercise 
tolerance, quality of life, limb muscle dysfunction, chronic disease 
 
PRESCRIPCIÓN DE EJERCICIO FÍSICO  
EN PACIENTES CON ENFERMEDAD  
PULMONAR OBSTRUCTIVA CRÓNICA 
 
RESUMEN 
La enfermedad pulmonar obstructiva crónica (EPOC) se caracteriza por la persistencia de síntomas 
respiratorios y limitación al flujo de aire. Además de las limitaciones ventilatorias, los pacientes con 
EPOC presentan una reducida capacidad para realizar ejercicio que limita su habilidad para realizar 
actividades de la vida diaria e impacta negativamente sobre su calidad de vida. La disfunción 
muscular de las extremidades es un síntoma sistémico consecuencia de la EPOC y está asociada con 
la intolerancia al ejercicio, la reducción de la calidad de vida y el aumento de la mortalidad. Este 
síndrome relacionado con la EPOC se caracteriza por la reducción del área de sección transversal 
del músculo esquelético, la fuerza y la resistencia, y es altamente prevalente entre los pacientes con 
EPOC. Así, la rehabilitación pulmonar (RP) está recomendada para combatir las consecuencias 
negativas de la EPOC sobre la capacidad para realizar ejercicio y la calidad de vida de los pacientes. 
El entrenamiento con ejercicio es considerado una pieza clave de la RP y puede implementarse en 
cualquier estadio de la enfermedad. Hasta la fecha, la combinación de entrenamiento de resistencia 
y fuerza (entrenamiento concurrente) ha demostrado ser la intervención con ejercicio más 
beneficiosa para la EPOC. El entrenamiento concurrente proporciona beneficios clínica y 
estadísticamente significativos con respecto a la tolerancia al ejercicio y calidad de vida de los 
pacientes con EPOC. Además, existen otras terapias y estrategias que potencialmente pueden 
complementar al entrenamiento con ejercicio para la mejora de la implementación de los 
programas de RP en pacientes con EPOC. 
Palabras clave: entrenamiento de fuerza, entrenamiento de resistencia, entrenamiento interválico, 
tolerancia al ejercicio, calidad de vida, disfunción muscular de las extremidades, enfermedad 
crónica 
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INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause 
of mortality around the world (Vogelmeier et al., 2017), and affects about 10% 
of the adult population above 40 years of age (Buist et al., 2007). COPD is 
defined as “a common, preventable and treatable disease that is characterized 
by persistent respiratory symptoms and airflow limitation that is due to airway 
and/or alveolar abnormalities usually caused by significant exposure to 
noxious particles or gases” (Vogelmeier et al., 2017). This chronic, progressive, 
and not fully reversible lung disease consists in a mixture of small airways 
diseases (e.g. obstructive bronchiolitis) and parenchymal destruction 
(emphysema), with patients showing dyspnea, chronic cough and/or sputum 
production (Vogelmeier et al., 2017). Exercise capacity is also severely 
impaired among patients with COPD (Mercken et al., 2005; Rabinovich et al., 
2001), limiting their ability to perform the activities of daily living and 
participate in social life. In addition, patients with COPD may experience 
exacerbations, which are episodes usually lasting 7-10 days associated with 
increased airway inflammation, mucus production and marked gas trapping 
that may require hospitalization, leading to increased dyspnea and functional 
decline (Maltais et al., 2014; Vogelmeier et al., 2017). 
Therefore, it is recommended for patients diagnosed with COPD to be 
immediately treated for their symptoms in order to prevent or slow down the 
progression of the disease. The exertional dyspnea is usually multifactorial in 
origin, partly reflecting limb muscle dysfunction, the consequences of dynamic 
hyperinflation, increased respiratory load, or defective gas exchange (Debigare 
& Maltais, 2008).  Thus, due to the complexity of COPD, its treatment must not 
be limited to the ventilatory limitations (i.e. chronic and progressive dyspnea) 
(Vogelmeier et al., 2017). There are other systemic consequences of COPD and 
associated comorbidities that have been reported to produce a further 
worsening in health-related quality of life (HRQoL) and increased mortality risk, 
which also need to be treated (Barnes & Celli, 2009; Sin, Anthonisen, Soriano, & 
Agusti, 2006). In this sense, exercise training has been demonstrated to be 
effective in the treatment of several of the most common comorbidities 
prevalent in patients with COPD (such as coronary heart disease, metabolic 
syndrome, osteoporosis or depression) (Pedersen & Saltin, 2015). In addition, 
exercise training is so far the most effective treatment for limb muscle 
dysfunction, a major systemic consequence of COPD (Maltais et al., 2014). Thus, 
our main goal was to provide the reader with the main evidence regarding the 
effects of exercise training on limb muscle dysfunction, exercise tolerance and 
HRQoL in patients with COPD, including the exercise parameters that should be 
prescribed in COPD patients in order to maximize the benefits derived from 
exercise training. 
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LIMB MUSCLE DYSFUNCTION IN COPD 
Limb muscle dysfunction is a systemic consequence of COPD characterized 
by the  presence of a decreased proportion of type I muscle fibers (Gosker, 
Zeegers, Wouters, & Schols, 2007) and oxidative capacity (Green et al., 2008), 
and reduced muscle cross-sectional area, strength and endurance (Couillard, 
Koechlin, Cristol, Varray, & Prefaut, 2002; Couillard et al., 2003). From the sixth 
decade of life, the annual decline in quadriceps strength increases in patients 
with COPD compared with the values usually observed in healthy older 
individuals (~ 4 vs 1.5%, respectively) (Hopkinson et al., 2007). On the 
contrary, the strength of the upper extremities seems to be better preserved 
than that of the lower extremities (Bernard et al., 1998).  
Importantly, limb muscle dysfunction has been found to be strongly 
associated with poor HRQoL, greater use of health care resources, and 
increased mortality in COPD (Decramer, Gosselink, Troosters, Verschueren, & 
Evers, 1997; Maltais et al., 2014; Marquis et al., 2002; Swallow et al., 2007). 
Therefore, the understanding of the main causes leading to limb muscle 
dysfunction in COPD and the potential therapies for its treatment is currently 
an important research focus. A particular characteristic of limb muscle 
dysfunction in COPD is that, in contrast with normal aging, there is a shift in 
fiber type distribution from type I fibers to type II fibers (Gosker et al., 2007). 
Much debate exists around the question whether limb muscle dysfunction is the 
result of years of physical inactivity or whether factors related to COPD might 
be involved. In other words, the question is whether limb muscle dysfunction in 
COPD is due to disuse or disease. It is well-known that physical inactivity (and 
immobilization) produce muscle weakness and atrophy, and lead to a reduced 
number of type I fibers, impaired oxidative enzyme capacity and decreased 
capillary-to-fiber ratio (Booth & Gollnick, 1983; Larsson & Ansved, 1985). 
However, there is evidence supporting the notion that differences in muscle 
function and structure between patients with COPD and healthy counterparts 
remain even when they present similar levels of physical activity (Couillard & 
Prefaut, 2005; Gifford et al., 2018). Thus, although physical inactivity and aging 
are important contributors to limb muscle dysfunction in COPD, it is likely that 
this situation may be aggravated by a myopathy associated with COPD. In this 
line, oxidative stress has been reported to be a major contributor to this 
myopathy in COPD (Couillard & Prefaut, 2005). Oxidative damage is the result 
of the imbalance between the production of reactive oxygen and nitrogen 
species and the tissue antioxidant capacity. This process can alter the structure 
and function of membrane lipids, proteins and DNA, eventually leading to cell 
injury and death (Wedzicha & Seemungal, 2007). Patients with COPD show 
increased levels of oxidative stress under resting and exercising conditions 
(Couillard et al., 2002; Couillard et al., 2003; Puig-Vilanova et al., 2015), which 
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are negatively associated with muscle mass, strength and exercise tolerance 
(Barreiro et al., 2009; Barreiro et al., 2008; Puig-Vilanova et al., 2015; van 
Helvoort et al., 2007; van Helvoort et al., 2006). In addition, other important 
contributors to limb muscle dysfunction are nutritional imbalance and the use 
of systemic corticosteroids (Maltais et al., 2014).  
Apart from smoking cessation, pharmacological therapy (overall 
bronchodilators, oral steroids, phosphodiesterase-4 inhibitors, theophylline 
and antibiotics) is on the front line for the prevention and treatment of COPD. 
However, no existing medication has proved to reduce the long-term decline in 
lung function and exercise capacity, while they do present several side-effects, 
such as increase in cardiovascular events (Anthonisen, Connett, Enright, & 
Manfreda, 2002; Michele, Pinheiro, & Iyasu, 2010), diabetes (Suissa, Kezouh, & 
Ernst, 2010), osteoporosis (Loke, Cavallazzi, & Singh, 2011; Pauwels et al., 
1999), nausea and weight loss (Chong, Leung, & Poole, 2017). Thus, COPD 
management requires additional evidence-based strategies able to counteract 
the negative consequences of this chronic and progressive disease. 
 
PULMONARY REHABILITATION AND EXERCISE TRAINING IN COPD 
Pulmonary rehabilitation (PR) is defined as “a comprehensive intervention 
based on a through patient assessment followed by patient-tailored therapies, 
which include, but are not limited to, exercise training, education, and behavior 
change, designed to improve the physical and psychological condition of people 
with chronic respiratory disease and to promote the long-term adherence of 
health-enhancing behaviors” (Spruit et al., 2013). PR can be implemented at 
any stage of the disease by an interdisciplinary team, including physicians and 
other health-related professionals (e.g. nurses, exercise physiologists, 
physiotherapists and nutritionists), with the main goals of minimizing 
symptom burden, improving exercise capacity and autonomy, increasing 
participation in everyday activities, and ultimately improving HRQoL (Spruit et 
al., 2013). Importantly, PR has demonstrated to improve HRQoL and exercise 
capacity in COPD patients (McCarthy et al., 2015; Puhan, Gimeno-Santos, Cates, 
& Troosters, 2016), even in those with mild COPD severity (Rugbjerg, Iepsen, 
Jorgensen, & Lange, 2015). Furthermore, the pooled results obtained from ten 
randomized controlled trials showed a significant reduction in hospital 
admissions derived from PR participation (Moore et al., 2016), which also 
occurred in those COPD patients who had recently suffered an exacerbation 
(Puhan et al., 2016). Preliminary meta-analytical evidence showed a positive 
effect of PR on mortality in patients with COPD (Puhan et al., 2011). However, 
in a recent update of the evidence, the effect of PR on mortality did not reach 
statistical significance, which the authors attributed to the great heterogeneity 
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observed across studies in the parameters prescribed in PR programs (Puhan 
et al., 2016). 
In this context, exercise training is regarded as the cornerstone of PR, and 
programs focusing mainly on exercise training have been found to achieve 
greater improvements in exercise capacity and HRQoL than those that do not 
integrate exercise training as a component (Kruis et al., 2014). The benefits and 
positive adaptations achieved by exercise training in COPD patients have been 
previously reviewed in the literature (De Brandt et al., 2016; De Brandt et al., 
2018). The evidence on the benefits of PR in COPD is such that the Cochrane 
Airways editorial board made the unusual decision of closing the review on this 
topic (Lacasse, Cates, McCarthy, & Welsh, 2015; McCarthy et al., 2015). Instead, 
it has been stated that future research should focus on further factors that 
remain uncertain, such as to find the optimal exercise parameters to maximize 
the benefits of PR in COPD (McCarthy et al., 2015). 
Exercise training programs encountered in the literature are usually based 
on guidelines from international organizations such as the American College of 
Sports Medicine (Ferguson, 2014), the American Thoracic Society/European 
Respiratory Society (Spruit et al., 2013), and the American Association of 
Cardiovascular and Pulmonary Rehabilitation (AACVPR) (AACVPR, 2011). All 
these organizations coincide in establishing endurance and resistance training 
as the core components of exercise prescription in COPD (Garvey et al., 2016), 
with some variations regarding exercise type, volume, intensity, frequency 
and/or progression. The main particularity of exercise training in COPD is the 
necessity of monitoring peripheral capillary oxygen saturation (SpO2) during 
exercise, which should be > 88%; and in case of SpO2 being ≤ 88% while 
breathing room air, supplemental oxygen should be used to maintain SpO2 at > 
88% (AACVPR, 2011; Ferguson, 2014). Apart from the latter, it has been stated 
that no differences exist in terms of training principles between patients with 
COPD and healthy individuals, meaning that “total training load must reflect the 
individual’s specific requirements, it must exceed loads encountered during 
daily life to improve aerobic capacity and muscle strength, and must progress 
as improvement occurs” (Spruit et al., 2013). 
 
Endurance training.  Exercise capacity has been reported to be reduced by 
50-70% in patients with COPD compared with healthy age-matched subjects 
(Bolton et al., 2007; Couillard et al., 2002; Mercken et al., 2005; Rabinovich et al., 
2001; Rodriguez et al., 2012). In addition, peripheral muscle endurance is 
severely impaired in COPD patients, with the magnitude of this decrease being 
highly variable (32-77%) (Maltais et al., 2014). Endurance training has been 
observed to elicit both central (e.g. enhancement of cardiac output via an 
increased stroke volume) and peripheral (e.g. increase in oxidative capacity and 
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capillary density) adaptations in people with COPD (Morris, Walsh, Adams, & 
Alision, 2016). These adaptations contribute to the improvement of maximal 
and submaximal exercise capacity, and to the reduction of the absolute and 
relative energy cost of activities of daily living. COPD patients have been 
reported to experience improvements in maximal exercise capacity ranging 
between 16-29% after participating in an 8-week endurance training program 
(Bolton et al., 2007; Mercken et al., 2005; Rabinovich et al., 2001; Rodriguez et 
al., 2012), with the benefits being potentially greater for longer training 
programs. Although there is strong evidence in support of the implementation 
of endurance training in patients with mild-to-severe COPD (Lacasse, Martin, 
Lasserson, & Goldstein, 2007; McCarthy et al., 2015; Paneroni, Simonelli, 
Vitacca, & Ambrosino, 2017; Salman, Mosier, Beasley, & Calkins, 2003), there is 
not consensus on the most appropriate endurance exercise parameters (e.g. 
type of exercise, duration, intensity and frequency) that should be prescribed in 
PR programs.  
In general, endurance training programs included in PR for COPD are 
usually conducted during 10 weeks (range: 3-16 weeks), with 2-3 sessions per 
week (range: 2-5 sessions), performing exercise on a cycle-ergometer or 
treadmill during 30-40 min (range: 20-45 min) at an average intensity of 60% 
of the peak power output (PPO) (range: 50 – 100% of PPO) (Zainuldin, Mackey, 
& Alison, 2011). When interval training is prescribed, a 1:1 - 1:2 work-to-rest 
ratio is used, with the duration of the exercise bout ranging from 20 s to 4 min 
(Zainuldin et al., 2011). However, a dose-response relationship has been 
reported to be difficult to establish in some cases because of the insufficient 
data and the heterogeneity across studies. There is evidence that supports the 
premise that the type of exercise should be focused on the skeletal muscles 
involved in the main activities of daily living in order to achieve greater benefits 
in functional performance and HRQoL. Thus, walking and cycling have been 
reported as more adequate activities for COPD management than swimming or 
paddling (Garvey et al., 2016). Furthermore, walking is considered to be the 
best training modality if the goal is to increase walking endurance (Leung, 
Alison, McKeough, & Peters, 2010). Although to our knowledge there are no 
studies comparing the effect of different training frequencies on the benefits 
derived from PR in people with COPD, all the selected guidelines agree in 
recommending 3 to 5 sessions per week (Garvey et al., 2016). In this line, a 
recent meta-analysis on the dose-response relationship of endurance training 
in sedentary older adults concluded that 3-4 sessions per week achieved the 
greatest benefits for cardiovascular fitness (Huang et al., 2016). On the other 
hand, exercising between 20 and 60 min has been suggested to be an adequate 
duration for exercise sessions in order to achieve substantial benefits, which 
might be partitioned in shorter bouts to cope with such recommendation in 
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individuals with moderate to severe COPD (Garvey et al., 2016). Much debate 
exists in terms of the optimal intensity at which endurance exercise should be 
performed. A meta-analysis concluded that, despite the fact that it is difficult to 
draw absolute conclusions, high-intensity endurance training programs might 
provide greater benefits in submaximal exercise capacity than moderate- or 
light-intensity endurance training programs (Zainuldin et al., 2011). This fact 
could be due to the greater ability of high-intensity endurance training 
programs to elicit aerobic and anaerobic adaptations in skeletal muscle 
metabolism (Casaburi et al., 1991). In addition, a moderate positive 
relationship between endurance exercise intensity and changes in PPO per 
hour of training (r = 0.68) has been reported, suggesting a dose-response 
relationship (Morris et al., 2016). Therefore, based on the studies collected in 
the previous meta-analysis, a threshold target of 70-80% of PPO may be 
necessary to elicit physiological improvements leading to increased exercise 
capacity, although lower intensities (≈ 30-40% PPO) could be enough to induce 
a reduction in symptoms, and an improvement in HRQoL and performance in 
activities of daily living (Zainuldin et al., 2011). 
Regarding the type of endurance training, both continuous and interval 
training have been reported to be equally effective to improve exercise and 
functional capacity, dyspnea and HRQoL when the total amount of work is 
matched (Zainuldin et al., 2011). However, the implementation of interval 
exercise might present some practical advantages to reach the previous 
recommendations on exercise intensity and duration. Time to exhaustion has 
been observed to be reduced to 5 and 13 min in COPD patients when intensities 
are set at 60-80% and 85-95% of PPO, respectively (Kortianou, Nasis, Spetsioti, 
Daskalakis, & Vogiatzis, 2010). Thus, a study that underwent two types of 
symptom-limited exercise tests in advanced COPD patients (forced expiratory 
volume in one second (FEV1) ≈ 40%) observed that the interval exercise 
protocol (30 s at 100% PPO + 30 s of unloaded pedalling until exhaustion) 
allowed a significantly longer exercise time (32-35 min vs 9-12 min) with lower 
metabolic (lactate: 3.9 vs 5.8 mmol·L-1) and ventilatory responses (33 vs 38 
L·min-1) than the continuous exercise protocol (80% of PPO until exhaustion) 
(Vogiatzis et al., 2004). In addition, the participants reported lower symptoms 
of dyspnea and leg fatigue during the interval compared with continuous 
exercise at isotime (Vogiatzis et al., 2004).  
Therefore, it seems that to achieve the goals of performing 20-60 min of 
endurance exercise at > 70-80% of PPO per session, interval exercise may be a 
more appropriate and comfortable strategy for patients with COPD. In this 
sense, several practical recommendations have been found in the literature 
(Kortianou et al., 2010): 1) The heavier the intensity of endurance exercise, the 
shorter the exercise bouts and the longer the rest intervals should be (e.g. for 
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intensity close to 100% of PPO, 20-30 s of active exercise plus 30-40 s of active 
or passive rest might be appropriate); 2) during resting periods, pursed-lip 
breathing might help to increase tidal volume and reduce breathing frequency, 
leading to a reduction in end-expiratory lung volume and an increment in 
arterial saturation, reducing breathlessness during exercise; and 3) leg 
discomfort and dyspnea should be monitored and maintained between 5-6 and 
3-4 points, respectively, in the 10-point Borg Scale of perceived exertion.  
Finally, longer PR programs (up to 18 months) have reported more 
favourable effects on HRQoL in patients with COPD when compared with 
shorter PR programs (Beauchamp, Janaudis-Ferreira, Goldstein, & Brooks, 
2011). Unfortunately, due to the small number of trials, the results for exercise 
capacity were less clear. It was suggested that while shorter exercise programs 
might improve exercise capacity in patients with COPD, longer exercise 
programs (> 6 months) may be necessary to induce long-term training effects 
and maintain  exercise capacity unchanged 12-18 months after training 
(Beauchamp et al., 2011). 
 
Resistance training. Exercise training in COPD has traditionally focused on 
endurance training alone. However, due to the strong evidence on the potential 
benefits of resistance training in COPD (Iepsen et al., 2015a, 2015b; Liao et al., 
2015; O'Shea, Taylor, & Paratz, 2004; Puhan, Schunemann, Frey, Scharplatz, & 
Bachmann, 2005; Strasser, Siebert, & Schobersberger, 2013), current 
recommendations strongly support the implementation of resistance training 
as a part of PR in patients with COPD (Garvey et al., 2016; Spruit et al., 2013). 
Resistance training programs have been demonstrated to provide greater gains 
in upper- and lower-body strength than endurance training programs (O'Shea 
et al., 2004), although in a more recent meta-analysis the difference did not 
reach statistical significance (Iepsen et al., 2015b). In addition, a positive effect 
on HRQoL after strength training has been reported when compared to a 
control group (O'Shea et al., 2004), although no differences were observed 
when compared to an endurance training group (Iepsen et al., 2015b). It is 
likely that the benefits of exercise training on HRQoL are not influenced by the 
type of exercise training. Moreover, it seems that it makes no (statistically 
significant) difference to perform resistance or endurance training in terms of 
adaptations in muscle strength, functional aerobic capacity, and peak oxygen 
uptake or peak workload attained during a graded incremental exercise 
protocol in COPD patients (Iepsen et al., 2015b). However, a meta-analysis 
including 11 randomized controlled trials and 331 participants with COPD 
concluded that when the two forms of exercise training were combined (i.e. 
concurrent training), the intervention provided greater adaptations in muscle 
strength than an exercise program including endurance training alone (Iepsen 
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et al., 2015a). In another meta-analysis including 18 randomized controlled 
trials involving 750 participants with COPD, combined endurance and 
resistance training greater improvements in leg press strength (weighted mean 
difference (WMD) of 12.3 kg, 95% CI 6.0 to 18.7 kg) and pectoral muscle 
strength (WMD of 4.5 kg, 95% CI 2.5 to 6.4) than endurance training alone 
(Liao et al., 2015). In addition, a positive effect on the St George Respiratory 
Questionnaire total scores (a questionnaire designed to evaluate health 
impairment in patients with COPD) was reported in the concurrent training 
group compared with the endurance training group (WMD of -7.4, 95% CI -12.6 
to 2.3) (Liao et al., 2015). Collectively, these findings indicate that the 
combination of resistance and endurance training provides greater benefits in 
muscle function and HRQoL than endurance training alone in patients with 
COPD. 
In regard to the potential benefit of resistance training on respiratory 
function in patients with COPD, a meta-analysis including a total of 14 
randomized controlled trials and 305 participants with COPD found a non-
statistically, neither clinically, significant improvement in absolute or 
percentage-of-predicted FEV1 (0.08 L and 2.71%, respectively; both p > 0.05) 
resulting from PR programs including resistance exercise (Strasser et al., 2013). 
By contrast, there was a statistically significant improvement in forced vital 
capacity with resistance training (0.37 L), and a positive trend was observed 
regarding peak ventilation (3.77 L·min-1; p = 0.08) (Strasser et al., 2013). 
Although the mechanisms for these adaptations remain unclear, the 
improvement in lung function with resistance training has been suggested to be 
due to the potential functional improvement of expiratory muscles (i.e. 
abdominal wall and internal intercostals). In addition, the improvement in lung 
mechanics (e.g. reduced physiological dead space/tidal volume ratios) (Clark, 
Cochrane, & Mackay, 1996), as a consequence of increased strength and the use 
of the abdominal muscles leading to a higher position of the diaphragm in the 
chest, might lead to the enhancement of lung function. Actually, resistance 
training has proven to enhance inspiratory muscle function, with a 16% 
increment in maximal inspiratory pressure (Ramirez-Venegas, Ward, Olmstead, 
Tosteson, & Mahler, 1997). 
The great heterogeneity observed across trials in some cases, and the 
insufficient data in other cases, have prevented the establishment of dose-
response relationships in relation to both intensity and volume of resistance 
training for COPD management. In general terms, resistance training programs 
in patients with COPD usually incorporate 2-3 sessions per week (in non-
consecutive days), in which on average, a total of six exercises (range: 3-9 
exercises) per session are performed targeting the trunk, upper limb and lower 
limb skeletal muscles, including 2-4 sets of 6-12 repetitions per exercise at 
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intensities ranging between 50-90% of one repetition maximum (1RM) (O'Shea 
et al., 2004; Strasser et al., 2013). The common dose at the end of the 
intervention has been reported to be 9 sets per muscle group per week (range: 
2-12 sets) (Strasser et al., 2013). In most cases, resistance training is 
administered by means of weight machines, although free weights can also be 
used, or a combination of both (O'Shea et al., 2004). In addition, training 
duration is typically 12 weeks (range: 6-26 weeks) (O'Shea et al., 2004; Strasser 
et al., 2013). Importantly no adverse events in any of the studies reviewed were 
reported (Iepsen et al., 2015a, 2015b; Liao et al., 2015; O'Shea et al., 2004), 
although as noted in these review works, no major adverse events should be 
expected as a consequence of exercise training when the type of training and 
level of intensity are adjusted individually. Attending to the evidence from two 
meta-analyses on the dose-response relationship of resistance training in the 
general older population, high-intensity resistance training (> 75-80% of 1RM) 
has been found to be superior to moderate- and light-intensity resistance 
training for the enhancement of maximal muscle strength (Csapo & Alegre, 
2016; Steib, Schoene, & Pfeifer, 2010), although this effect was substantially 
smaller when training protocols were matched for mechanical work (Csapo & 
Alegre, 2016). In addition, training twice a week produced similar effects in 
muscle strength to training three times a week, but it had a higher effect than 
training once weekly (Steib et al., 2010). Another meta-analysis confirmed the 
previous findings and added that performing 2-3 sets per exercise of 7-9 
repetitions at 70-79% of the 1RM with an inter-set rest interval of at least 60 s 
provided the greatest adaptations in muscle strength in healthy older adults 
(Borde, Hortobagyi, & Granacher, 2015). Furthermore, resistance training 
interventions lasting 50-53 weeks were found to be superior to achieve greater 
gains in muscle strength compared to shorter interventions (Borde et al., 2015). 
Training to failure was not observed to generate greater muscle adaptations 
than not training to failure, with training volume as a more important feature to 
achieve morphological muscle adaptations in older adults (da Silva et al., 2018). 
This fact matches with the preference of patients with COPD to increase 
resistance or load rather than increase the number of repetitions per set until 
exhaustion (Ries, Ellis, & Hawkins, 1988). Finally, supervised training has been 
found to be superior to unsupervised training in improving measures of 
dynamic steady-state balance and measures of muscle strength/power in 
healthy older adults (Lacroix, Hortobagyi, Beurskens, & Granacher, 2017). Even 
small amounts of supervised sessions within mainly unsupervised 
interventions seem to have a beneficial extra effect (Lacroix et al., 2017). In 
general, the previous results obtained from the meta-analyses including older 
adults (i.e. not specifically with COPD) might help in optimizing the exercise 
parameters included in resistance training programs in COPD patients, 
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although most of the previous recommendations are in consonance with the 
general characteristics of the resistance training programs reported in patients 
with COPD (O'Shea et al., 2004; Strasser et al., 2013). On the other hand, 
exercise intensity has not been found to influence functional adaptations in 
older people (Steib et al., 2010). Actually, muscle power and maximal angular 
velocity of movement are key determinants of functional performance in older 
adults (Alcazar, Rodriguez-Lopez, et al., 2018; Byrne, Faure, Keene, & Lamb, 
2016), and high-velocity resistance training or power training have been 
reported to be superior to traditional resistance training to increase muscle 
power (Steib et al., 2010) and functional performance in older people (Straight, 
Lindheimer, Brady, Dishman, & Evans, 2016; Tschopp, Sattelmayer, & Hilfiker, 
2011) independent of training intensity. The main difference between power 
training and traditional resistance training is that, in the first case, concentric 
repetitions are performed as fast as possible. This characteristic has 
demonstrated to decrease cardiovascular loading (Lamotte, Fleury, Pirard, 
Jamon, & van de Borne, 2010) and increase muscle oxygenation (Tanimoto & 
Ishii, 2006) during resistance exercise in comparison with traditional 
resistance training, which makes power training a potentially more suitable 
approach for patients with COPD. Both power training and testing have been 
reported to be safe in aging populations (Alcazar, Guadalupe-Grau, Garcia-
Garcia, Ara, & Alegre, 2018; Porter, 2006). In any case, future studies should 
evaluate the effects of high-velocity resistance training or power training in 
patients with COPD. 
 
Considerations for concurrent training programs 
Concurrent training (combining continuous or interval endurance training 
and resistance training) has been demonstrated to be feasible and safe in 
patients with COPD (Bolton et al., 2007; Guadalupe-Grau et al., 2017). Since the 
current guidelines recommend the implementation of both endurance and 
resistance training (i.e. concurrent training) within PR in COPD (Garvey et al., 
2016; Spruit et al., 2013), there are several aspects that should be considered in 
order to optimize training adaptations. In terms of training frequency, 
concurrent training performed twice a week was observed to promote similar 
adaptations when compared with three times per week in previously trained 
elderly men (Ferrari et al., 2016). The exercise sequence within the sessions (i.e. 
performing endurance prior to resistance training vs resistance prior to 
endurance training) has been found to influence the benefits derived from 
concurrent training. While the intra-session exercise sequence had no influence 
in maximal and submaximal endurance adaptations (Cadore et al., 2018), the 
implementation of resistance prior to endurance training three times per week 
elicited superior adaptations in lower-body muscle strength, muscle quality 
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and rectus femoris neuromuscular economy in older adults (Cadore et al., 2012; 
Cadore et al., 2013). However, another study found no differences between 
exercise sequences regarding muscle adaptations (muscle strength and power, 
functional performance, electromyographic activity, and rectus femoris echo 
intensity) when it was performed twice a week (Wilhelm et al., 2014). Although 
there is evidence indicating a positive effect derived from performing 
resistance prior to endurance training, great heterogeneity exists across studies 
with people older than 50 years old (Murlasits, Kneffel, & Thalib, 2018). Thus, 
we could follow the recommendation of implementing resistance prior to 
endurance training in older people and people with COPD, although more 
studies are needed in order to strengthen this evidence. Another way to avoid a 
possible interference effect of endurance training on resistance training-
induced muscle adaptations would be to perform both type of exercises on 
alternate days (Cadore & Izquierdo, 2013). In this sense, even a minimum dose 
of one session per week of resistance training and one session per week of cycle 
endurance training has been reported to promote positive and substantial 
adaptations in muscle strength, power and endurance in older adults (Cadore & 
Izquierdo, 2013). 
 
Other potential interventions. Neuromuscular electrical stimulation (NMES) 
has been presented as a useful training modality that might be included in PR 
programs for COPD patients (Maltais et al., 2014; Spruit et al., 2013). NMES 
consists in the depolarization of motor neurons (inducing muscle contraction) 
by the application of an electrical current through electrodes placed on the skin 
located over the targeted muscles. NMES has demonstrated to augment lower-
limb muscle function when compared with a non-exercise control group (Bax, 
Staes, & Verhagen, 2005). However, volitional training seems to be superior to 
NMES when the participants do not present limitations to perform volitional 
resistance exercises (Bax et al., 2005). Otherwise, in case of immobilization due 
to injury, illness or disability (e.g. COPD-related exacerbation requiring 
hospitalization), NMES may be more effective than volitional training (Bax et al., 
2005). Thus, a meta-analysis demonstrated that NMES improved quadriceps 
muscle strength, exercise capacity and 6-min walking distance (6-MWD) 
performance in moderate-to-severe patients with COPD (Chen et al., 2016). By 
contrast, NMES did not improve HRQoL in these patients (Chen et al., 2016). 
Therefore, NMES might be recommendable in severely disabled patients with 
COPD, unstable patients, during exacerbations, and in general, in those cases in 
which the tolerance to volitional exercise training is severely compromised 
(Maltais et al., 2014). NMES may also be applicable for home use (Neder et al., 
2002) or as an adjunct to volitional resistance training. The methodological 
considerations for the use of NMES are beyond the scope of the present 
Julian Alcazar; Carlos Rodriguez-Lopez; Ana Alfaro-Acha …        Exercise prescription … 
 
 
European Journal of Human Movement, 2018: 41, 73-102 86 
manuscript, so the interested readers are referred to other review works on the 
topic (Bergquist et al., 2011; Maffiuletti, 2010; Maffiuletti et al., 2018).  
Respiratory muscle training has been postulated as another beneficial form 
of training for patients with COPD (Spruit et al., 2013). The main goal of 
respiratory training is to enhance inspiratory and/or expiratory muscle 
strength and endurance, in order to reduce dyspnea, increase exercise capacity 
and improve HRQoL. To do this, inspiratory and expiratory muscles are 
subjected to airflow restriction (e.g. with the use of an external device), or 
different breathing techniques may be performed to strengthen respiratory 
muscles. The evidence obtained from the literature points out that respiratory 
muscle training programs are typically performed 2-7 days/week during 1-52 
weeks at an intensity of 30-80% of maximal inspiratory capacity (Beaumont, 
Forget, Couturaud, & Reychler, 2018; Geddes, O'Brien, Reid, Brooks, & Crowe, 
2008; Holland, Hill, Jones, & McDonald, 2012; Neves et al., 2014; O'Brien, 
Geddes, Reid, Brooks, & Crowe, 2008).  The evidence points out that inspiratory 
muscle training (IMT) programs are effective to significantly improve maximal 
inspiratory capacity [WMD of 12.0 cmH20, 95% CI 10.0 to 14.0] (Beaumont et 
al., 2018). In addition, clinically and statistically significant improvements in 
the baseline-transition dyspnea index and functional exercise capacity (6-MWD 
performance) were derived from inspiratory muscle training when compared 
to a non-exercise control group [WMD of 2.3 points, 95% CI 1.7 to 2.9; and 
WMD of 42.7 m, 95% CI 16.9 to 68.5, respectively]. However, these gains were 
not accompanied by neither statistically nor clinically significant improvements 
in HRQoL (Beaumont et al., 2018), and no significant differences were found 
when IMT was compared to a PR incorporating exercise training (O'Brien et al., 
2008). Adding IMT to exercise training enhanced maximal inspiratory capacity 
further than exercise training alone [WMD of 8.6 cmH2O, 95% CI 2.6 to 14.7], 
but not significant differences were observed in terms of exercise capacity and 
dyspnea (Beaumont et al., 2018; O'Brien et al., 2008). In addition, several 
breathing techniques (e.g. diaphragmatic breathing, pursed-lip breathing and 
ventilation feedback training) have been found to be effective in improving 
exercise tolerance (ranging from 35 to 88 m in 6-MWD test) without any impact 
in dyspnea and HRQoL in severe to very severe COPD patients (Holland et al., 
2012).  However, the addition of breathing techniques to exercise training did 
not provide additional benefits for dyspnea, exercise tolerance or HRQoL 
compared to exercise training alone (Holland et al., 2012). Therefore, breathing 
exercises may be useful for individuals who are not able to take part in 
exercise-based pulmonary rehabilitation programmes (Holland et al., 2012). 
On the other hand, the addition of activity counselling to PR improved the 
levels of physical activity in patients with COPD in comparison to PR alone, 
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leading to significant increases that exceeded the minimal important difference 
for daily steps in COPD (Lahham, McDonald, & Holland, 2016). 
Flexibility training has also been indicated as an additional training mode 
to be integrated in PR programs (Garvey et al., 2016; Spruit et al., 2013). 
However, it is also acknowledged that there is no evidence supporting the 
implementation of flexibility training in the management of COPD (Garvey et al., 
2016; Spruit et al., 2013), and thus, its inclusion as a component of PR might be 
considered futile, or at least questionable in the majority of patients with COPD.  
There might be other potential adjuncts to exercise training that may 
maximize its effects (Spruit et al., 2013). For example, an optimal 
pharmacological dose (e.g. bronchodilators) (Casaburi, Kukafka, Cooper, Witek, 
& Kesten, 2005) or the application of noninvasive positive pressure ventilation 
(Corner & Garrod, 2010) during exercise might reduce the work and/or unload 
the respiratory muscles and change the primary focus of exercise limitation 
from dyspnea to leg fatigue, increasing the ability of the individuals to sustain a 
higher exercise intensity. By contrast, the administration of oxygen and helium-
hyperoxic gas mixtures has been reported to bring inconsistent results (Spruit 
et al., 2013). On the other hand, anabolic hormonal supplementation in 
combination with exercise training in those patients presenting low levels of 
anabolic steroids (i.e. testosterone and its analogs) may improve adaptations in 
muscle mass and strength, with no adverse events when low doses are 
prescribed in the short term (Casaburi et al., 2004). However, more research is 
needed in order to confirm such findings and extend the exercise 
recommendations to other therapies that in combination with exercise might 
potentiate its benefits. 
 
Further considerations on the implementation of PR in people with COPD 
PR is one of the most cost-effective treatment interventions available for 
patients with COPD (Rochester et al., 2015) and it is associated with a 
substantial reduction in hospitalizations and healthcare costs (Griffiths et al., 
2000; Griffiths, Phillips, Davies, Burr, & Campbell, 2001; Group, 2004; Raskin et 
al., 2006). Its cost-effectiveness is superior to some of the main 
pharmacological options (such as Tiotropium, LABA and triple therapy) 
(Zoumot, Jordan, & Hopkinson, 2014). Despite this high level of evidence, 
implementation of PR in people with COPD is very low (Johnston & Grimmer-
Somers, 2010). It has been reported that only 1-9% of eligible patients with 
COPD attend a PR program each year (Calle Rubio et al., 2017; Yohannes & 
Connolly, 2004). The main reasons for this problematic situation are the non-
participation of referred patients in PR programs and the non-referral of 
eligible patients to PR programs by healthcare professionals. Thus, a systematic 
review observed that the percentage of referred participants who did not 
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attend PR at all ranged from 8 to 50% (Keating, Lee, & Holland, 2011). In 
addition, among those patients who did initiate the PR program, 10-32% 
dropped-out and did not complete the program (Keating et al., 2011). The main 
barriers reported by the patients who did not attend and/or complete the PR 
program were difficulties with transportation, mobility, distance and location 
of programs, and the disruption to already established personal activities or 
routines (Keating et al., 2011; Thorpe, Johnston, & Kumar, 2012). The lack of 
perceived benefit and the influence of the participant’s doctor were also 
reported by some patients among other barriers to participation in a PR 
program (Keating et al., 2011; Thorpe et al., 2012). None of the common 
physiological and clinical variables (e.g. dyspnea or disease severity) showed a 
consistent association with non-attendance and/or completion of the PR 
program (Keating et al., 2011). However, the problem does not seem to be just 
the attendance and completion of PR programs by the referred patients, but 
also the referral of patients by healthcare professionals. Despite strong 
evidence and international recommendations acknowledging the benefits 
derived from the implementation of PR at any stage of the disease, including 
from stable patients to patients just discharged from the intensive care unit 
after respiratory failure (Bailey et al., 2007; Morris et al., 2008), the median 
referral rate has been reported to be as low as 17% (Milner, Boruff, 
Beaurepaire, Ahmed, & Janaudis-Ferreira, 2018). The main healthcare 
professional perceived barriers to referral were: low knowledge of, or disbelief 
in, the benefits of PR; low knowledge of the referral process; low knowledge of 
patient eligibility criteria; low awareness of PR; and the belief that it would be 
too difficult to achieve a behaviour change in patients or that patients would 
not take responsibility of their disease (Milner et al., 2018). In regard to this 
problematic situation, an official American Thoracic Society/European 
Respiratory Society policy statement has recently been published, to which 
those readers interested in enhancing implementation, use and delivery of PR 
are referred to (Rochester et al., 2015). Overall, the improvement of the 
knowledge of the benefits of PR and exercise training in COPD patients among 
healthcare professionals might enhance PR referral, while the implementation 
of home-based exercise training programs (Liu et al., 2014) or the use of NMES 
at home (Chen et al., 2016) might be indicated in COPD patients unable to 
attend the PR facilities. 
 
CONCLUSIONS 
PR has been demonstrated to improve limb muscle dysfunction, exercise 
capacity and quality of life, and reduce healthcare use in COPD patients. 
Exercise training is considered as the cornerstone of PR, and its inclusion in PR 
programs has demonstrated to increase the benefit derived from PR. Therefore, 
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supervised exercise training is recommended in patients with COPD at any 
stage of the disease (figure 1). Exercise should be addressed to both upper- and 
lower-body muscles, acknowledging that lower-limb muscles have a greater 
influence on exercise capacity and quality of life in COPD patients. High-
intensity endurance training is recommended on a basis of 3-5 sessions per 
week and 20-60 min per session, with interval endurance training being a more 
feasible approach to reach such recommendations in people with COPD. On the 
other hand, high-intensity resistance training is recommended on a basis of 2 
sessions per week, performing 2-3 sets of 7-9 repetitions per exercise with an 
inter-set rest interval of at least 60 s. The combination of endurance and 
resistance training (i.e. concurrent training) has been observed to enhance the 
training-induced adaptations in muscle function and quality of life. In this sense, 
performing resistance prior to endurance training within the training sessions 
might obtain greater adaptations. Other potential adjuncts to concurrent 
training exist, such as NMES, respiratory muscle training and physical activity 
counselling, which might maximize the benefits derived from exercise and/or 
facilitate the participation of COPD patients in PR programs. Finally, the 
application of educational programs targeting healthcare professionals in order 
to improve the general understanding of the benefits of PR in COPD 
management might improve the referral and implementation of PR programs in 














FIGURE 1: Summary of the current evidence-based recommendations for the 
prescription of supervised exercise training programs in patients with chronic 
obstructive pulmonary disease. Exercise training programs should be adjusted to the 
individual characteristics and requirements of each subject. In general, training load 
must exceed loads encountered during daily life to improve aerobic and muscle function. 
Therefore, some subjects may benefit from less strenuous exercise programs than those 
based on the recommendations given in the present figure. These recommendations 
may be updated by novel evidence presented in future studies. Note: 1RM, one 
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